Tuesday, July 13, 2010

Trivascular Raises $60M

Santa Rosa-based Trivascular, a developer of medical stent graft systems for treating aortic aneurysms, said this week that it has raised $60M in a Series C funding round. The round was led by Pinnacle Ventures, and also included New Enterprise Associates (NEA), Delphi Ventures, MPM Capital and Kearny Venture Partners. As part of the investment, Pinnacle's David J. Kim and NEA's Ryan Drant have both joined the firm's board. The firm said the funding will go toward launching its Ovation Abdominal Stent Graft System in Europe. More information »